World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
104
Citations
50249
World Ranking
6948
National Ranking
212

Overview

Vincent Cottin is affiliated with Claude Bernard University Lyon 1 in France. Their research primarily focuses on Medicine, with extensive work in the fields of Pulmonary and Respiratory Medicine, Physiology, Pathology and Forensic Medicine, Rheumatology, and Epidemiology.

The scientist has contributed significantly to several main research topics, including:

  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
  • Sarcoidosis and Beryllium Toxicity Research
  • Systemic Sclerosis and Related Diseases
  • Pulmonary Hypertension Research and Treatments
  • Medical Imaging and Pathology Studies
  • Occupational and environmental lung diseases
  • Eosinophilic Disorders and Syndromes

Vincent Cottin has published in numerous scientific venues, with a notable presence in:

  • Revue des Maladies Respiratoires Actualités
  • European Respiratory Journal
  • American Journal of Respiratory and Critical Care Medicine
  • La Revue de Médecine Interne
  • Pneumologie

Frequent co-authors associated with this scientist include:

  • Bruno Crestani
  • Raphaël Borie
  • Hilario Nunès
  • S. Jouneau
  • S. Marchand-Adam

Recent significant papers authored or co-authored by Vincent Cottin include:

  • Spectrum of Fibrotic Lung Diseases, 2020, New England Journal of Medicine
  • Nintedanib in patients with progressive fibrosing interstitial lung diseases-subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial, 2020, The Lancet Respiratory Medicine
  • Progressive fibrosing interstitial lung disease: clinical uncertainties, consensus recommendations, and research priorities, 2020, The Lancet Respiratory Medicine
  • The natural history of progressive fibrosing interstitial lung diseases, 2020, European Respiratory Journal
  • Evidence-Based Guideline for the diagnosis and management of eosinophilic granulomatosis with polyangiitis, 2023, Nature Reviews Rheumatology

Best Publications

  • Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis

    Luca Richeldi;Roland M. du Bois;Ganesh Raghu;Arata Azuma

  • An Official American Thoracic Society/European Respiratory Society Statement: Update of the International Multidisciplinary Classification of the Idiopathic Interstitial Pneumonias

    William D. Travis;Ulrich Costabel;David M. Hansell;Talmadge E. King

  • Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline.

    Ganesh Raghu;Martine Remy-Jardin;Jeffrey L. Myers;Luca Richeldi

  • Survival in Patients With Idiopathic, Familial, and Anorexigen-Associated Pulmonary Arterial Hypertension in the Modern Management Era

    Marc Humbert;Olivier Sitbon;Ari Chaouat;Michèle Bertocchi

  • International guidelines for the diagnosis and management of hereditary haemorrhagic telangiectasia

    M E Faughnan;V A Palda;G Garcia-Tsao;U W Geisthoff

  • An official European Respiratory Society/American Thoracic Society research statement: interstitial pneumonia with autoimmune features

    Aryeh Fischer;Katerina M. Antoniou;Kevin K. Brown;Jacques Cadranel

  • Pulmonary hypertension due to left heart diseases.

    Jean-Luc Vachiery;Yochai Adir;Joan Albert Barberà;Hunter C. Champion

  • European Respiratory Society guidelines for the diagnosis and management of lymphangioleiomyomatosis

    S R Johnson;J F Cordier;R Lazor;R Lazor;V Cottin

  • Risk assessment, prognosis and guideline implementation in pulmonary arterial hypertension.

    Athénaïs Boucly;Athénaïs Boucly;Jason Weatherald;Jason Weatherald;Laurent Savale;Laurent Savale;Xavier Jaïs;Xavier Jaïs

  • Presentation, diagnosis and clinical course of the spectrum of progressive-fibrosing interstitial lung diseases

    Vincent Cottin;Nikhil A. Hirani;David L. Hotchkin;Anoop M. Nambiar

  • Eosinophilic granulomatosis with polyangiitis (Churg-Strauss) (EGPA) Consensus Task Force recommendations for evaluation and management.

    Matthieu Groh;Christian Pagnoux;Chiara Baldini;Elisabeth Bel

  • MUC5B Promoter Variant and Rheumatoid Arthritis with Interstitial Lung Disease.

    Pierre-Antoine Juge;Joyce S Lee;Esther Ebstein;Hiroshi Furukawa

  • Pirfenidone in patients with unclassifiable progressive fibrosing interstitial lung disease: a double-blind, randomised, placebo-controlled, phase 2 trial.

    Toby M Maher;Toby M Maher;Tamera J Corte;Tamera J Corte;Aryeh Fischer;Aryeh Fischer;Michael Kreuter

  • Nintedanib in patients with idiopathic pulmonary fibrosis: Combined evidence from the TOMORROW and INPULSIS® trials

    Luca Richeldi;Vincent Cottin;Roland M. du Bois;Moisés Selman

  • Treatment of idiopathic pulmonary fibrosis with etanercept: an exploratory, placebo-controlled trial.

    Ganesh Raghu;Kevin K. Brown;Ulrich Costabel;Vincent Cottin

  • Nintedanib in patients with progressive fibrosing interstitial lung diseases—subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial

    Athol U. Wells;Kevin R. Flaherty;Kevin K. Brown;Yoshikazu Inoue

  • Upfront triple combination therapy in pulmonary arterial hypertension: a pilot study

    Olivier Sitbon;Xavier Jaïs;Laurent Savale;Vincent Cottin

  • The pathogenesis of pulmonary fibrosis: a moving target

    Wim A Wuyts;Carlo Agostini;Katerina M Antoniou;Demosthenes Bouros

  • Pulmonary Arteriovenous Malformations in Patients with Hereditary Hemorrhagic Telangiectasia

    Vincent Cottin;Henri Plauchu;Jean-Yves Bayle;Martine Barthelet

  • Interstitial lung disease in amyopathic dermatomyositis, dermatomyositis and polymyositis

    V. Cottin;F. Thivolet-Bejui;M. Reynaud-Gaubert;J. Cadranel

Frequent Co-Authors

Jean-François Cordier
Jean-François Cordier Claude Bernard University Lyon 1
Marc Humbert
Marc Humbert University of Paris-Saclay
Toby M. Maher
Toby M. Maher University of Southern California
Gérald Simonneau
Gérald Simonneau University of Paris-Saclay
Dominique Valeyre
Dominique Valeyre Université Paris Cité
David Montani
David Montani University of Paris-Saclay
Athol U. Wells
Athol U. Wells Imperial College London
Olivier Sitbon
Olivier Sitbon University of Paris-Saclay
Luca Richeldi
Luca Richeldi Catholic University of the Sacred Heart
Xavier Jaïs
Xavier Jaïs University of Paris-Saclay

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring healthcare careers in the USA doesn’t always mean following the traditional medical school route. For those seeking flexibility, numerous online programs open doors to various roles in healthcare. For registered nurses aiming to advance as nurse practitioners, asn to fnp programs offer a streamlined path from associate degrees to family nurse practitioner credentials.

If your interests lie in preventive health, an online bachelor's degree in nutrition can lead to jobs in wellness education, clinical dietetics, or community health. Administrative careers in hospitals and healthcare systems are also in demand; earning a degree through cahme accredited online mha programs ensures you have the right credentials for leadership roles.

Many nurses want to advance their expertise without the burden of extra clinical hours, making online rn to bsn programs no clinicals an ideal option. No matter your preferred pathway, these accredited online degrees deliver the skills needed for growing healthcare careers—all while maintaining work-life flexibility.

Best Scientists Citing Vincent Cottin

Trending Scientists

Recently Published Articles